Albuterol
A fast-acting bronchodilator that relaxes the muscles surrounding the airways in the lungs, allowing them to widen and making it easier to breathe during asthma attacks or other episodes of airway narrowing. It works within minutes of inhalation and is one of the most widely used rescue medications for acute breathing difficulties.
Molekularmasse
239,3110 g/mol
LogP
0,30
TPSA
72,70 Ų
Lipinski-Regel der Fünf
Bestanden
Therapeutische Bereiche
Arzneimittelklassen
Wirkmechanismus
Selective beta-2 adrenergic receptor agonist causing bronchodilation.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Selective beta-2 adrenergic receptor agonist causing bronchodilation.
2D-Struktur
Cite this structure
Embed this structure
SMILES
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
InChI
InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3
Molecular Formula
C13H21NO3
HBD / HBA
4 / 4
Rotierbare Bindungen
5
Schwere Atome
17
Propranolol, a non-selective beta-blocker, directly antagonises the bronchodilatory and cardiovascular effects of albuterol, potentially causing severe bronchospasm in patients with asthma or COPD.
Albuterol-induced hypokalaemia can potentiate digoxin toxicity by increasing myocardial sensitivity to digoxin at any given plasma concentration.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
A fast-acting bronchodilator that relaxes the muscles surrounding the airways in the lungs, allowing them to widen and making it easier to breathe during asthma attacks or other episodes of airway narrowing. It works within minutes of inhalation and is one of the most widely used rescue medications for acute breathing difficulties.
Selective beta-2 adrenergic receptor agonist causing bronchodilation.
Key pharmacokinetic parameters for Albuterol: Half-life: 3-8 hours.
Yes, Albuterol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
Related Drugs
Same Drug Class
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL714. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2083. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="albuterol"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/albuterol/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/albuterol/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/albuterol/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="albuterol"></drugfyi-drug>